Mediconlic wide screen blood glucose monitoring system - Taiwan Registration bce88b1d3e2864ad121f15800e9beea6
Access comprehensive regulatory information for Mediconlic wide screen blood glucose monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number bce88b1d3e2864ad121f15800e9beea6 and manufactured by 訊影Optoelectronics Co., Ltd.;; Medicon Technology Co., Ltd. The authorized representative in Taiwan is MEDICARE TECH CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is only for in vitro testing, quantitatively detecting the blood glucose value of fresh microvascular whole blood from fingertips and other blood collection sites (palm, forearm, upper arm, calf and thigh), and is not suitable for neonatal testing. This product can be used by professional medical professionals or diabetic patients to measure blood glucose levels, and is not intended as the final diagnosis of diabetes.
A Clinical Chemistry and Clinical Toxicology;; I General, Plastic Surgery and Dermatology
I.4800 Manual instruments for general surgery; A.1345 Glucose Test System
Contract manufacturing;; Domestic
Dates and Status
Jul 18, 2019
Jul 18, 2029